SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cosmos Holdings Inc. – ‘8-K’ for 7/16/18

On:  Thursday, 7/19/18, at 11:01am ET   ·   For:  7/16/18   ·   Accession #:  1477932-18-3568   ·   File #:  0-54436

Previous ‘8-K’:  ‘8-K’ on 6/26/18 for 6/23/18   ·   Next:  ‘8-K’ on 9/5/18 for 9/4/18   ·   Latest:  ‘8-K/A’ on 5/3/24 for 4/26/24   ·   16 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/19/18  Cosmos Holdings Inc.              8-K:8,9     7/16/18    2:133K                                   Discount Edgar/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     12K 
 2: EX-10.1     Share Exchange Agreement                            HTML    103K 


8-K   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT 

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   

 

Date of Report (Date of earliest event reported) July 16, 2018 

 

Cosmos Holdings Inc.

(Exact name of registrant as specified in its charter)

  

Nevada

 

000-54436

 

27-0611758 

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

  

141 West Jackson Blvd, Suite 4236, Chicago, Illinois  

 

60604 

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code (312) 865-0026

 

N/A

 (Former name or former address, if changed since last report.) 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter). 

 

Emerging growth company o  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o  

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c)) 

 

 
 
 
 

 

ITEM 8.01. OTHER EVENTS.

 

On July 16, 2018, Cosmos Holdings Inc. (the “Company”) completed a Share Exchange Agreement (the “SEA”) by and among Marathon Global Inc. (“Marathon”), a corporation incorporated under the laws of the Province of Ontario, Canada; Kaneh Bosm Biotechnology Inc. (“KBB”), a corporation incorporated under the laws of the Province of British Colombia and a public reporting company on the Canadian Securities Exchange; and certain other sellers of Marathon capital stock. Pursuant to a prior Securities Exchange Agreement, as amended on May 24, 2018, the Company had transferred one-half of its interest in Marathon to KBB in exchange for five million shares of KBB. Pursuant to the terms of the new SEA, the Company transferred its remaining one-half interest in Marathon to KBB. The Company received an additional five million shares of KBB. Completion of the SEA by the Company was subject to satisfaction of various conditions precedent all of which have been satisfied. The ten million shares of KBB owned by the Company constitute approximately 7% of the 141,219,108 shares of capital stock of KBB issued and outstanding.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

  

 

 

(d) Item No.

 

Exhibits - Description

 

 

 

10.1

 

Share Exchange Agreement dated as of June 26, 2018.

 

 

2

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

COSMOS HOLDINGS INC.

     

Date: July 19, 2018

By:

/s/ Grigorios Siokas

 

 

Grigorios Siokas

 
   

Chief Executive Officer

 
       

 

3

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:7/19/18
For Period End:7/16/18
5/24/188-K
 List all Filings 


16 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/29/24  Cosmos Health Inc.                S-3                    4:460K                                   Discount Edgar/FA
 8/18/23  Cosmos Health Inc.                S-3                    4:521K                                   Discount Edgar/FA
 4/12/23  Cosmos Health Inc.                10-K       12/31/22   95:10M                                    Discount Edgar/FA
 1/18/23  Cosmos Health Inc.                S-3                    4:530K                                   Discount Edgar/FA
12/16/22  Cosmos Health Inc.                10-K/A     12/31/21   91:9.1M                                   Discount Edgar/FA
12/01/22  Cosmos Health Inc.                S-3/A                  4:452K                                   Discount Edgar/FA
11/07/22  Cosmos Health Inc.                S-3/A                  3:480K                                   Discount Edgar/FA
10/14/22  Cosmos Health Inc.                S-1/A                  2:204K                                   Discount Edgar/FA
10/13/22  Cosmos Health Inc.                S-1/A      10/12/22    3:228K                                   Discount Edgar/FA
10/11/22  Cosmos Health Inc.                S-1/A                 94:14M                                    Discount Edgar/FA
 9/21/22  Cosmos Health Inc.                S-3         9/22/22    4:741K                                   Discount Edgar/FA
 9/19/22  Cosmos Health Inc.                S-1                   90:14M                                    Discount Edgar/FA
 6/07/22  Cosmos Health Inc.                S-1/A                  3:191K                                   Discount Edgar/FA
 5/25/22  Cosmos Health Inc.                S-1         5/24/22   90:13M                                    Discount Edgar/FA
 4/15/22  Cosmos Health Inc.                10-K       12/31/21   91:9.6M                                   Discount Edgar/FA
 4/15/21  Cosmos Health Inc.                10-K       12/31/20   86:7.8M                                   Discount Edgar/FA
Top
Filing Submission 0001477932-18-003568   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 3, 9:19:35.2pm ET